ADAM33 expression in atherosclerotic lesions and relationship of ADAM33 gene variation with atherosclerosis

Atherosclerosis

Volumn 211, Issue 1, 2010, Pages 224-230

  Holloway, John W ^a   Laxton, Ross C ^a,c   Rose Zerilli, Matthew J ^a   Holloway, Judith A ^a   Andrews, A Lynn ^a   Riaz, Zeshan ^a   Wilson, Susan J ^a   Simpson, Iain A ^b   Ye, Shu ^a,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

ADAM33; Atherosclerosis; Genetic; Polymorphism; Smooth muscle cells

Indexed keywords

ADAM PROTEIN; ADAM33 PROTEIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; ADAM33 PROTEIN, HUMAN;

ADULT; AGED; ARTERY MUSCLE; ARTERY WALL; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BASEMENT MEMBRANE; CELL MIGRATION; COHORT ANALYSIS; CORONARY ARTERY DISEASE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; BIOSYNTHESIS; CELL MOTION; DRUG EFFECTS; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAM PROTEINS; AGED; ATHEROSCLEROSIS; CELL MOVEMENT; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77954309262     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.02.023     Document Type: Article

References (18)

1. Lusis A.J. Atherosclerosis. Nature 2000, 407(6801):233-241.
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340(2):115-126.
3. Duffy M.J., Lynn D.J., Lloyd A.T., O'Shea C.M. The ADAMs family of proteins: from basic studies to potential clinical applications. Thromb Haemost 2003, 89(4):622-631.
4. Van E.P., Little R.D., Dupuis J., et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002, 418(6896):426-430.
5. Herren B., Raines E.W., Ross R. Expression of a disintegrin-like protein in cultured human vascular cells and in vivo. FASEB J 1997, 11(2):173-180.
6. Lu D., Xie S., Sukkar M.B., et al. Inhibition of airway smooth muscle adhesion and migration by the disintegrin domain of ADAM-15. Am J Respir Cell Mol Biol 2007, 37(4):494-500.
7. Powell R.M., Wicks J., Holloway J.W., Holgate S.T., Davies D.E. The splicing and fate of ADAM33 transcripts in primary human airways fibroblasts. Am J Respir Cell Mol Biol 2004, 31(1):13-21.
8. Richter A., Puddicombe S.M., Lordan J.L., et al. The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 2001, 25(3):385-391.
9. Yang Y., Haitchi H.M., Cakebread J., et al. Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells. J Allergy Clin Immunol 2008, 121(6). 1393-9, 1399.
10. Ye S., Dunleavey L., Bannister W., et al. Independent effects of the -219 G>T and epsilon 2/epsilon 3/epsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: the Southampton Atherosclerosis Study. Eur J Hum Genet 2003, 11(6):437-443.
11. Simpson A., Maniatis N., Jury F., et al. Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function. Am J Respir Crit Care Med 2005, 172(1):55-60.
12. Huang J., Bridges L.C., White J.M. Selective modulation of integrin-mediated cell migration by distinct ADAM family members. Mol Biol Cell 2005, 16(10):4982-4991.
13. White J.M. ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 2003, 15(5):598-606.
14. Gilpin B.J., Loechel F., Mattei M.G., et al. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem 1998, 273(1):157-166.
15. Puxeddu I., Pang Y.Y., Harvey A., et al. The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma. J Allergy Clin Immunol 2008, 121(6):1400-1406e4.
16. Umland S.P., Garlisi C.G., Shah H., et al. Human ADAM33 messenger RNA expression profile and post-transcriptional regulation. Am J Respir Cell Mol Biol 2003, 29(5):571-582.
17. Zou J., Zhu F., Liu J., et al. Catalytic activity of human ADAM33. J Biol Chem 2004, 279(11):9818-9830.
18. Blakey J., Halapi E., Bjornsdottir U.S., et al. Contribution of ADAM33 polymorphisms to the population risk of asthma. Thorax 2005, 60(4):274-276.